Preparation and performance of artificial dermis based on recombinant humanized type III collagen and carboxymethyl chitosan

Artificial dermis is a biological substitute material that mimics the structure and function of human skin, which can protect wounds, guide the reconstruction of the dermal layer, and promote wound healing. Currently, most artificial dermis products employ collagen extracted from animals, but this poses potential risks of rejection and infection during clinical applications. The development of novel artificial dermis formulations capable of mitigating these limitations holds significant clinical importance. In this study, a bilayer artificial dermis composed of a silicone membrane and a collagen sponge was designed. The collagen sponge was formed through genipin-mediated cross-linking of recombinant humanized type III collagen (rhCOL III) and carboxymethyl chitosan (CMCS). The artificial dermis exhibited a bilayer structure comprising a silicone membrane layer and a collagen sponge layer. All artificial dermis groups exhibited favorable porosity, mechanical properties, and hydrophilicity. With increasing CMCS concentration, the material's swelling properties, moisture retention, and resistance to degradation gradually improved. Among these concentrations, CMCS contents of 3%(w/v) and 4%(w/v) exhibited the best performance. The results of hemolysis testing and various cell experiments indicated that the material had great blood compatibility and cytocompatibility. Mouse dorsal whole cortical defect models further confirmed that all experimental groups had been able to promote wound healing, with the 4%(w/v) CMCS group showing the fastest wound recovery rate. Histopathological analysis via hematoxylin and eosin and Masson's trichrome staining revealed well-organized collagen alignment in high-concentration CMCS groups, particularly in the 4%(w/v) CMCS group, accompanied by complete epidermal restoration and nascent skin appendage formation. The epidermis layer was restored to a smooth state and skin appendages were regenerated.

Authors

Institutions

Publication Details

Journal
Biomedical Materials
Published
2026-01-05
DOI
https://doi.org/10.1088/1748-605x/ae334b
Primary Topic
Wound Healing and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Preparation and performance of artificial dermis based on recombinant humanized type III collagen and carboxymethyl chitosan

Lanju Xu, Yufei Liu, Shufang Wang, S F Nie et al.
Biomedical Materials
Wound Healing and Treatments
article

Preparation and performance of artificial dermis based on recombinant humanized type III collagen and carboxymethyl chitosan

Lanju Xu, Yufei Liu, Shufang Wang, S F Nie, Siyin Chen, Jiawen Wei, Yiming Wang, Zhisheng Chang, Miao Gu, Zhenzong Xue
article en

Abstract

Artificial dermis is a biological substitute material that mimics the structure and function of human skin, which can protect wounds, guide the reconstruction of the dermal layer, and promote wound healing. Currently, most artificial dermis products employ collagen extracted from animals, but this poses potential risks of rejection and infection during clinical applications. The development of novel artificial dermis formulations capable of mitigating these limitations holds significant clinical importance. In this study, a bilayer artificial dermis composed of a silicone membrane and a collagen sponge was designed. The collagen sponge was formed through genipin-mediated cross-linking of recombinant humanized type III collagen (rhCOL III) and carboxymethyl chitosan (CMCS). The artificial dermis exhibited a bilayer structure comprising a silicone membrane layer and a collagen sponge layer. All artificial dermis groups exhibited favorable porosity, mechanical properties, and hydrophilicity. With increasing CMCS concentration, the material's swelling properties, moisture retention, and resistance to degradation gradually improved. Among these concentrations, CMCS contents of 3%(w/v) and 4%(w/v) exhibited the best performance. The results of hemolysis testing and various cell experiments indicated that the material had great blood compatibility and cytocompatibility. Mouse dorsal whole cortical defect models further confirmed that all experimental groups had been able to promote wound healing, with the 4%(w/v) CMCS group showing the fastest wound recovery rate. Histopathological analysis via hematoxylin and eosin and Masson's trichrome staining revealed well-organized collagen alignment in high-concentration CMCS groups, particularly in the 4%(w/v) CMCS group, accompanied by complete epidermal restoration and nascent skin appendage formation. The epidermis layer was restored to a smooth state and skin appendages were regenerated.

Biomedical MaterialsVol. 21(1)
Nankai University (CN), Hospital of Hebei Province (CN), Shenzhen International Travel Health Care Center (CN), HBIS (China) (CN)
Openalex Percentile: Top 97%
Wound Healing and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.